Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria. Reply
N Engl J Med
.
2019 May 9;380(19):1876.
doi: 10.1056/NEJMc1902327.
Authors
Justin A Green
1
,
Gavin C K W Koh
1
,
Stephan Duparc
2
Affiliations
1
GlaxoSmithKline, Stockley Park West, United Kingdom justin.a.green@gsk.com.
2
Medicines for Malaria Venture, Geneva, Switzerland.
PMID:
31067385
DOI:
10.1056/NEJMc1902327
No abstract available
Publication types
Letter
Comment
MeSH terms
Aminoquinolines
Humans
Malaria, Vivax*
Plasmodium vivax
Primaquine*
Recurrence
Substances
Aminoquinolines
tafenoquine
Primaquine